Skip to main content
Top
Published in: Journal of Inflammation 1/2011

Open Access 01-12-2011 | Research

Insulin alleviates degradation of skeletal muscle protein by inhibiting the ubiquitin-proteasome system in septic rats

Authors: Qiyi Chen, Ning Li, Weiming Zhu, Weiqin Li, Shaoqiu Tang, Wenkui Yu, Tao Gao, Juanjuan Zhang, Jieshou Li

Published in: Journal of Inflammation | Issue 1/2011

Login to get access

Abstract

Hypercatabolism is common under septic conditions. Skeletal muscle is the main target organ for hypercatabolism, and this phenomenon is a vital factor in the deterioration of recovery in septic patients. In skeletal muscle, activation of the ubiquitin-proteasome system plays an important role in hypercatabolism under septic status. Insulin is a vital anticatabolic hormone and previous evidence suggests that insulin administration inhibits various steps in the ubiquitin-proteasome system. However, whether insulin can alleviate the degradation of skeletal muscle protein by inhibiting the ubiquitin-proteasome system under septic condition is unclear. This paper confirmed that mRNA and protein levels of the ubiquitin-proteasome system were upregulated and molecular markers of skeletal muscle proteolysis (tyrosine and 3-methylhistidine) simultaneously increased in the skeletal muscle of septic rats. Septic rats were infused with insulin at a constant rate of 2.4 mU.kg-1.min-1 for 8 hours. Concentrations of mRNA and proteins of the ubiquitin-proteasome system and molecular markers of skeletal muscle proteolysis were mildly affected. When the insulin infusion dose increased to 4.8 mU.kg-1.min-1, mRNA for ubiquitin, E2-14 KDa, and the C2 subunit were all sharply downregulated. At the same time, the levels of ubiquitinated proteins, E2-14KDa, and the C2 subunit protein were significantly reduced. Tyrosine and 3-methylhistidine decreased significantly. We concluded that the ubiquitin-proteasome system is important skeletal muscle hypercatabolism in septic rats. Infusion of insulin can reverse the detrimental metabolism of skeletal muscle by inhibiting the ubiquitin-proteasome system, and the effect is proportional to the insulin infusion dose.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hasselgren PO: Role of the ubiquitin-proteasome pathway in sepsis-induced muscle catabolism. Mol Biol Rep. 1999, 26 (1-2): 71-6.PubMedCrossRef Hasselgren PO: Role of the ubiquitin-proteasome pathway in sepsis-induced muscle catabolism. Mol Biol Rep. 1999, 26 (1-2): 71-6.PubMedCrossRef
2.
go back to reference Lin SY, Chen WY, Lee FY, Huang CJ, Sheu WH: Activation of ubiquitin-proteasome pathway is involved in skeletal muscle wasting in a rat model with biliary cirrhosis: potential role of TNF-alpha. Am J Physiol Endocrinol Metab. 2005, 288 (3): E493-501.PubMedCrossRef Lin SY, Chen WY, Lee FY, Huang CJ, Sheu WH: Activation of ubiquitin-proteasome pathway is involved in skeletal muscle wasting in a rat model with biliary cirrhosis: potential role of TNF-alpha. Am J Physiol Endocrinol Metab. 2005, 288 (3): E493-501.PubMedCrossRef
3.
go back to reference Tiao G, Hobler S, Wang JJ: Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle. J Clin Invest. 1997, 99 (2): 163-8. 10.1172/JCI119143.PubMedPubMedCentralCrossRef Tiao G, Hobler S, Wang JJ: Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle. J Clin Invest. 1997, 99 (2): 163-8. 10.1172/JCI119143.PubMedPubMedCentralCrossRef
4.
go back to reference Hasselgren PO, Fischer JE: The ubiquitin-proteasome pathway: review of a novel intracellular mechanism of muscle protein breakdown during sepsis and other catabolic conditions. Ann Surg. 1997, 225 (3): 307-16. 10.1097/00000658-199703000-00011.PubMedPubMedCentralCrossRef Hasselgren PO, Fischer JE: The ubiquitin-proteasome pathway: review of a novel intracellular mechanism of muscle protein breakdown during sepsis and other catabolic conditions. Ann Surg. 1997, 225 (3): 307-16. 10.1097/00000658-199703000-00011.PubMedPubMedCentralCrossRef
5.
go back to reference Klaude M, Fredriksson K, Tjader I: Proteasome proteolytic activity in skeletal muscle is increased in patients with sepsis. Clin Sci (Lond). 2007, 112 (9): 499-506. 10.1042/CS20060265.CrossRef Klaude M, Fredriksson K, Tjader I: Proteasome proteolytic activity in skeletal muscle is increased in patients with sepsis. Clin Sci (Lond). 2007, 112 (9): 499-506. 10.1042/CS20060265.CrossRef
6.
go back to reference Minnaard R, Wagenmakers AJ, Combaret L: Ubiquitin-proteasome-dependent proteolytic activity remains elevated after zymosan-induced sepsis in rats while muscle mass recovers. Int J Biochem Cell Biol. 2005, 37 (10): 2217-25. 10.1016/j.biocel.2005.05.002.PubMedCrossRef Minnaard R, Wagenmakers AJ, Combaret L: Ubiquitin-proteasome-dependent proteolytic activity remains elevated after zymosan-induced sepsis in rats while muscle mass recovers. Int J Biochem Cell Biol. 2005, 37 (10): 2217-25. 10.1016/j.biocel.2005.05.002.PubMedCrossRef
7.
go back to reference Dardevet D, Sornet C, Taillandier D, Savary I, Attaix D, Grizard J: Sensitivity and protein turnover response to glucocorticoids are different in skeletal muscle from adult and old rats. Lack of regulation of the ubiquitin-proteasome proteolytic pathway in aging. J Clin Invest. 1995, 96 (5): 2113-9. 10.1172/JCI118264.PubMedPubMedCentralCrossRef Dardevet D, Sornet C, Taillandier D, Savary I, Attaix D, Grizard J: Sensitivity and protein turnover response to glucocorticoids are different in skeletal muscle from adult and old rats. Lack of regulation of the ubiquitin-proteasome proteolytic pathway in aging. J Clin Invest. 1995, 96 (5): 2113-9. 10.1172/JCI118264.PubMedPubMedCentralCrossRef
8.
go back to reference Hobler SC, Wang JJ, Williams AB: Sepsis is associated with increased ubiquitinconjugating enzyme E214k mRNA in skeletal muscle. Am J Physiol. 1999, 276 (2 Pt 2): R468-73.PubMed Hobler SC, Wang JJ, Williams AB: Sepsis is associated with increased ubiquitinconjugating enzyme E214k mRNA in skeletal muscle. Am J Physiol. 1999, 276 (2 Pt 2): R468-73.PubMed
9.
go back to reference Rajan VR, Mitch WE: Muscle wasting in chronic kidney disease: the role of the ubiquitin proteasome system and its clinical impact. Pediatr Nephrol. 2008, 23 (4): 527-35. 10.1007/s00467-007-0594-z.PubMedPubMedCentralCrossRef Rajan VR, Mitch WE: Muscle wasting in chronic kidney disease: the role of the ubiquitin proteasome system and its clinical impact. Pediatr Nephrol. 2008, 23 (4): 527-35. 10.1007/s00467-007-0594-z.PubMedPubMedCentralCrossRef
10.
go back to reference Solomon V, Madihally S, Yarmush M, Toner M: Insulin suppresses the increased activities of lysosomal cathepsins and ubiquitin conjugation system in burn-injured rats. J Surg Res. 2000, 93 (1): 120-6. 10.1006/jsre.2000.5958.PubMedCrossRef Solomon V, Madihally S, Yarmush M, Toner M: Insulin suppresses the increased activities of lysosomal cathepsins and ubiquitin conjugation system in burn-injured rats. J Surg Res. 2000, 93 (1): 120-6. 10.1006/jsre.2000.5958.PubMedCrossRef
11.
go back to reference Solomon V, Madihally S, Mitchell RN, Yarmush M, Toner M: Antiproteolytic action of insulin in burn-injured rats. J Surg Res. 2002, 105 (2): 234-42. 10.1006/jsre.2002.6355.PubMedCrossRef Solomon V, Madihally S, Mitchell RN, Yarmush M, Toner M: Antiproteolytic action of insulin in burn-injured rats. J Surg Res. 2002, 105 (2): 234-42. 10.1006/jsre.2002.6355.PubMedCrossRef
12.
go back to reference Van den Berghe G, Wilmer A, Hermans G: Intensive insulin therapy in the medical ICU. N Engl J Med. 2006, 354 (5): 449-61. 10.1056/NEJMoa052521.PubMedCrossRef Van den Berghe G, Wilmer A, Hermans G: Intensive insulin therapy in the medical ICU. N Engl J Med. 2006, 354 (5): 449-61. 10.1056/NEJMoa052521.PubMedCrossRef
13.
go back to reference Price SR, Bailey JL, Wang X: Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin-proteasome proteolytic pathway by a mechanism including gene transcription. J Clin Invest. 1996, 98 (8): 1703-8. 10.1172/JCI118968.PubMedPubMedCentralCrossRef Price SR, Bailey JL, Wang X: Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin-proteasome proteolytic pathway by a mechanism including gene transcription. J Clin Invest. 1996, 98 (8): 1703-8. 10.1172/JCI118968.PubMedPubMedCentralCrossRef
14.
go back to reference Mitch WE, Bailey JL, Wang X, Jurkovitz C, Newby D, Price SR: Evaluation of signals activating ubiquitin-proteasome proteolysis in a model of muscle wasting. Am J Physiol. 1999, 276 (5 Pt 1): C1132-8.PubMed Mitch WE, Bailey JL, Wang X, Jurkovitz C, Newby D, Price SR: Evaluation of signals activating ubiquitin-proteasome proteolysis in a model of muscle wasting. Am J Physiol. 1999, 276 (5 Pt 1): C1132-8.PubMed
15.
go back to reference Hu J, Klein JD, Du J, Wang XH: Cardiac muscle protein catabolism in diabetes mellitus: activation of the ubiquitin-proteasome system by insulin deficiency. Endocrinology. 2008, 149 (11): 5384-90. 10.1210/en.2008-0132.PubMedPubMedCentralCrossRef Hu J, Klein JD, Du J, Wang XH: Cardiac muscle protein catabolism in diabetes mellitus: activation of the ubiquitin-proteasome system by insulin deficiency. Endocrinology. 2008, 149 (11): 5384-90. 10.1210/en.2008-0132.PubMedPubMedCentralCrossRef
16.
go back to reference Wang X, Hu Z, Hu J, Du J, Mitch WE: Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology. 2006, 147 (9): 4160-8. 10.1210/en.2006-0251.PubMedCrossRef Wang X, Hu Z, Hu J, Du J, Mitch WE: Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology. 2006, 147 (9): 4160-8. 10.1210/en.2006-0251.PubMedCrossRef
17.
go back to reference Wing SS, Banville D: 14-kDa ubiquitin-conjugating enzyme: structure of the rat gene and regulation upon fasting and by insulin. Am J Physiol. 1994, 267 (1 Pt 1): E39-48.PubMed Wing SS, Banville D: 14-kDa ubiquitin-conjugating enzyme: structure of the rat gene and regulation upon fasting and by insulin. Am J Physiol. 1994, 267 (1 Pt 1): E39-48.PubMed
18.
go back to reference Sadiq F, Hazlerigg DG, Lomax MA: Amino acids and insulin act additively to regulate components of the ubiquitin-proteasome pathway in C2C12 myotubes. BMC Mol Biol. 2007, 8: 23-10.1186/1471-2199-8-23.PubMedPubMedCentralCrossRef Sadiq F, Hazlerigg DG, Lomax MA: Amino acids and insulin act additively to regulate components of the ubiquitin-proteasome pathway in C2C12 myotubes. BMC Mol Biol. 2007, 8: 23-10.1186/1471-2199-8-23.PubMedPubMedCentralCrossRef
19.
go back to reference Sugita H, Kaneki M, Tokunaga E: Inducible nitric oxide synthase plays a role in LPS-induced hyperglycemia and insulin resistance. Am J Physiol Endocrinol Metab. 2002, 282 (2): E386-94.PubMedCrossRef Sugita H, Kaneki M, Tokunaga E: Inducible nitric oxide synthase plays a role in LPS-induced hyperglycemia and insulin resistance. Am J Physiol Endocrinol Metab. 2002, 282 (2): E386-94.PubMedCrossRef
20.
go back to reference Ling PR, Lydon E, Qu Z, Frederich RC, Bistrian BR: Metabolic effects of insulin and insulin-like growth factor-I in endotoxemic rats during total parenteral nutrition feeding. Metabolism. 2000, 49 (5): 611-5. 10.1016/S0026-0495(00)80036-0.PubMedCrossRef Ling PR, Lydon E, Qu Z, Frederich RC, Bistrian BR: Metabolic effects of insulin and insulin-like growth factor-I in endotoxemic rats during total parenteral nutrition feeding. Metabolism. 2000, 49 (5): 611-5. 10.1016/S0026-0495(00)80036-0.PubMedCrossRef
21.
go back to reference Tisdale MJ: The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting. J Support Oncol. 2005, 3 (3): 209-17.PubMed Tisdale MJ: The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting. J Support Oncol. 2005, 3 (3): 209-17.PubMed
22.
go back to reference Wing SS: Control of ubiquitination in skeletal muscle wasting. Int J Biochem Cell Biol. 2005, 37 (10): 2075-87. 10.1016/j.biocel.2004.11.011.PubMedCrossRef Wing SS: Control of ubiquitination in skeletal muscle wasting. Int J Biochem Cell Biol. 2005, 37 (10): 2075-87. 10.1016/j.biocel.2004.11.011.PubMedCrossRef
23.
go back to reference Wray CJ, Mammen JM, Hershko DD, Hasselgren PO: Sepsis upregulates the gene expression of multiple ubiquitin ligases in skeletal muscle. Int J Biochem Cell Biol. 2003, 35 (5): 698-705. 10.1016/S1357-2725(02)00341-2.PubMedCrossRef Wray CJ, Mammen JM, Hershko DD, Hasselgren PO: Sepsis upregulates the gene expression of multiple ubiquitin ligases in skeletal muscle. Int J Biochem Cell Biol. 2003, 35 (5): 698-705. 10.1016/S1357-2725(02)00341-2.PubMedCrossRef
24.
go back to reference Breen HB, Espat NJ: The ubiquitin-proteasome proteolysis pathway: potential target for disease intervention. JPEN J Parenter Enteral Nutr. 2004, 28 (4): 272-7. 10.1177/0148607104028004272.PubMedCrossRef Breen HB, Espat NJ: The ubiquitin-proteasome proteolysis pathway: potential target for disease intervention. JPEN J Parenter Enteral Nutr. 2004, 28 (4): 272-7. 10.1177/0148607104028004272.PubMedCrossRef
25.
go back to reference Chai J, Wu Y, Sheng ZZ: Role of ubiquitin-proteasome pathway in skeletal muscle wasting in rats with endotoxemia. Crit Care Med. 2003, 31 (6): 1802-7. 10.1097/01.CCM.0000069728.49939.E4.PubMedCrossRef Chai J, Wu Y, Sheng ZZ: Role of ubiquitin-proteasome pathway in skeletal muscle wasting in rats with endotoxemia. Crit Care Med. 2003, 31 (6): 1802-7. 10.1097/01.CCM.0000069728.49939.E4.PubMedCrossRef
26.
go back to reference Olberding KE, Kelley ML, Butler RA, Van Beneden RJ: A HECT E3 ubiquitin-protein ligase with sequence similarity to E6AP does not target p53 for degradation in the softshell clam (Mya arenaria). Mutat Res. 2004, 552 (1-2): 61-71.PubMedCrossRef Olberding KE, Kelley ML, Butler RA, Van Beneden RJ: A HECT E3 ubiquitin-protein ligase with sequence similarity to E6AP does not target p53 for degradation in the softshell clam (Mya arenaria). Mutat Res. 2004, 552 (1-2): 61-71.PubMedCrossRef
27.
go back to reference Tiao G, Hobler S, Wang JJ: Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle. J Clin Invest. 1997, 99 (2): 163-8. 10.1172/JCI119143.PubMedPubMedCentralCrossRef Tiao G, Hobler S, Wang JJ: Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle. J Clin Invest. 1997, 99 (2): 163-8. 10.1172/JCI119143.PubMedPubMedCentralCrossRef
28.
go back to reference Tisdale MJ: The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting. J Support Oncol. 2005, 3 (3): 209-17.PubMed Tisdale MJ: The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting. J Support Oncol. 2005, 3 (3): 209-17.PubMed
29.
go back to reference Glass DJ: PI3 kinase regulation of skeletal muscle hypertrophy and atrophy. Curr Top Microbiol Immunol. 2010, 346: 267-78. 10.1007/82_2010_78.PubMed Glass DJ: PI3 kinase regulation of skeletal muscle hypertrophy and atrophy. Curr Top Microbiol Immunol. 2010, 346: 267-78. 10.1007/82_2010_78.PubMed
30.
go back to reference Stitt TN, Drujan D, Clarke BA: The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell. 2004, 14 (3): 395-403. 10.1016/S1097-2765(04)00211-4.PubMedCrossRef Stitt TN, Drujan D, Clarke BA: The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell. 2004, 14 (3): 395-403. 10.1016/S1097-2765(04)00211-4.PubMedCrossRef
31.
go back to reference Lee SW, Dai G, Hu Z: Regulation of muscle protein degradation: coordinated control of apoptotic and ubiquitin-proteasome systems by phosphatidylinositol 3 kinase. J Am Soc Nephrol. 2004, 15 (6): 1537-45. 10.1097/01.ASN.0000127211.86206.E1.PubMedCrossRef Lee SW, Dai G, Hu Z: Regulation of muscle protein degradation: coordinated control of apoptotic and ubiquitin-proteasome systems by phosphatidylinositol 3 kinase. J Am Soc Nephrol. 2004, 15 (6): 1537-45. 10.1097/01.ASN.0000127211.86206.E1.PubMedCrossRef
32.
go back to reference Griesdale DE, de Souza RJ, van DRM: Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ. 2009, 180 (8): 821-7.PubMedPubMedCentralCrossRef Griesdale DE, de Souza RJ, van DRM: Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ. 2009, 180 (8): 821-7.PubMedPubMedCentralCrossRef
33.
go back to reference Yu WK, Li WQ, Li N, Li JS: Influence of acute hyperglycemia in human sepsis on inflammatory cytokine and counterregulatory hormone concentrations. World J Gastroenterol. 2003, 9 (8): 1824-7.PubMedPubMedCentralCrossRef Yu WK, Li WQ, Li N, Li JS: Influence of acute hyperglycemia in human sepsis on inflammatory cytokine and counterregulatory hormone concentrations. World J Gastroenterol. 2003, 9 (8): 1824-7.PubMedPubMedCentralCrossRef
34.
go back to reference Wang X, Hu Z, Hu J, Du J, Mitch WE: Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology. 2006, 147 (9): 4160-8. 10.1210/en.2006-0251.PubMedCrossRef Wang X, Hu Z, Hu J, Du J, Mitch WE: Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology. 2006, 147 (9): 4160-8. 10.1210/en.2006-0251.PubMedCrossRef
35.
go back to reference Yu WK, Li WQ, Wang XD: Influence and mechanism of a tight control of blood glucose by intensive insulin therapy on human sepsis. Zhonghua Wai Ke Za Zhi. 2005, 43 (1): 29-32.PubMed Yu WK, Li WQ, Wang XD: Influence and mechanism of a tight control of blood glucose by intensive insulin therapy on human sepsis. Zhonghua Wai Ke Za Zhi. 2005, 43 (1): 29-32.PubMed
36.
go back to reference Llovera M, Garcia-Martinez C, Agell N, Lopez-Soriano FJ, Argiles JM: TNF can directly induce the expression of ubiquitin-dependent proteolytic system in rat soleus muscles. Biochem Biophys Res Commun. 1997, 230 (2): 238-41. 10.1006/bbrc.1996.5827.PubMedCrossRef Llovera M, Garcia-Martinez C, Agell N, Lopez-Soriano FJ, Argiles JM: TNF can directly induce the expression of ubiquitin-dependent proteolytic system in rat soleus muscles. Biochem Biophys Res Commun. 1997, 230 (2): 238-41. 10.1006/bbrc.1996.5827.PubMedCrossRef
37.
go back to reference DeMartino GN, Slaughter CA: Regulatory proteins of the proteasome. Enzyme Protein. 1993, 47 (4-6): 314-24.PubMed DeMartino GN, Slaughter CA: Regulatory proteins of the proteasome. Enzyme Protein. 1993, 47 (4-6): 314-24.PubMed
38.
go back to reference Duckworth WC, Bennett RG, Hamel FG: A direct inhibitory effect of insulin on a cytosolic proteolytic complex containing insulin-degrading enzyme and multicatalytic proteinase. J Biol Chem. 1994, 269 (40): 24575-80.PubMed Duckworth WC, Bennett RG, Hamel FG: A direct inhibitory effect of insulin on a cytosolic proteolytic complex containing insulin-degrading enzyme and multicatalytic proteinase. J Biol Chem. 1994, 269 (40): 24575-80.PubMed
39.
go back to reference Hamel FG, Bennett RG, Harmon KS, Duckworth WC: Insulin inhibition of proteasome activity in intact cells. Biochem Biophys Res Commun. 1997, 234 (3): 671-4. 10.1006/bbrc.1997.6693.PubMedCrossRef Hamel FG, Bennett RG, Harmon KS, Duckworth WC: Insulin inhibition of proteasome activity in intact cells. Biochem Biophys Res Commun. 1997, 234 (3): 671-4. 10.1006/bbrc.1997.6693.PubMedCrossRef
Metadata
Title
Insulin alleviates degradation of skeletal muscle protein by inhibiting the ubiquitin-proteasome system in septic rats
Authors
Qiyi Chen
Ning Li
Weiming Zhu
Weiqin Li
Shaoqiu Tang
Wenkui Yu
Tao Gao
Juanjuan Zhang
Jieshou Li
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Journal of Inflammation / Issue 1/2011
Electronic ISSN: 1476-9255
DOI
https://doi.org/10.1186/1476-9255-8-13

Other articles of this Issue 1/2011

Journal of Inflammation 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.